SUBCUTANEOUS MEDROXYPROGESTERONE ACETATE FOR TREATMENT OF MENOPAUSE AND ENDOMETRIOSIS
OA: closed
AI-generated summary
This patent describes methods for treating menopause and endometriosis in human females through the subcutaneous administration of hormonal replacement agents, specifically progestogens or progestogen-estrogen combinations.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
One aspect of the present invention is a method of human female menopause treatment which comprises subcutaneous administration of a menopausely effective amount of a hormonal replacement agent selected from the group consisting of a progestogen and a progestogen plus an estrogen. Another aspect of the present invention is treating endometriosis.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-07-18T06:13:54.626559+00:00